CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion
<p>Abstract</p> <p>Background</p> <p>Cisplatin is more often used to treat ovarian cancer (OvCa), which provides modest survival advantage primarily due to chemo-resistance and up regulated anti-apoptotic machineries in OvCa cells. Therefore, targeting the mechanisms re...
Saved in:
Main Authors: | Johnson Erica L (Author), Singh Rajesh (Author), Johnson-Holiday Crystal M (Author), Grizzle William E (Author), Partridge Edward E (Author), Lillard James W (Author), Singh Shailesh (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway
by: Xiaoyi Qi, et al.
Published: (2023) -
Bufotalin Induces Oxidative Stress-Mediated Apoptosis by Blocking the ITGB4/FAK/ERK Pathway in Glioblastoma
by: Junchao Tan, et al.
Published: (2024) -
Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways
by: Shengwen Cheng, et al.
Published: (2023) -
A piRNA-like Small RNA Induces Chemoresistance to Cisplatin-Based Therapy by Inhibiting Apoptosis in Lung Squamous Cell Carcinoma
by: Yuyan Wang, et al.
Published: (2017) -
Berberine Improves Chemo-Sensitivity to Cisplatin by Enhancing Cell Apoptosis and Repressing PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer
by: Yingying Kou, et al.
Published: (2020)